CZ212297A3 - Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of gynecological diseases - Google Patents

Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of gynecological diseases Download PDF

Info

Publication number
CZ212297A3
CZ212297A3 CZ972122A CZ212297A CZ212297A3 CZ 212297 A3 CZ212297 A3 CZ 212297A3 CZ 972122 A CZ972122 A CZ 972122A CZ 212297 A CZ212297 A CZ 212297A CZ 212297 A3 CZ212297 A3 CZ 212297A3
Authority
CZ
Czechia
Prior art keywords
pharmaceutically acceptable
compound
formula
hydrogen
prophylaxis
Prior art date
Application number
CZ972122A
Other languages
Czech (cs)
English (en)
Inventor
Martin William Edwards
James Robertson Piggott
Virender Mohan Labroo
Ved Prakash Kamboj
Suprabhat Ray
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of CZ212297A3 publication Critical patent/CZ212297A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ972122A 1995-01-13 1996-01-10 Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of gynecological diseases CZ212297A3 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DK4595 1995-01-13
DK4495 1995-01-13
DK4695 1995-01-13
DK4895 1995-01-13
DK4795 1995-01-13
DK77195 1995-06-30
DK77095 1995-06-30
DK76895 1995-06-30
DK77295 1995-06-30
DK76995 1995-06-30
PCT/DK1996/000015 WO1996021444A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders

Publications (1)

Publication Number Publication Date
CZ212297A3 true CZ212297A3 (en) 1997-11-12

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ972122A CZ212297A3 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of gynecological diseases

Country Status (11)

Country Link
EP (1) EP0804190A1 (hu)
JP (1) JPH10511962A (hu)
CN (1) CN1168096A (hu)
AU (1) AU693628B2 (hu)
CA (1) CA2208861A1 (hu)
CZ (1) CZ212297A3 (hu)
HU (1) HUP9702244A3 (hu)
IL (1) IL116746A0 (hu)
MX (1) MX9705219A (hu)
NO (1) NO973243L (hu)
WO (1) WO1996021444A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
EP0934297A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
CA2270111A1 (en) * 1996-10-28 1998-05-07 Lise Brown Christiansen Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CA2270113A1 (en) * 1996-10-28 1998-05-07 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
DE69717843T2 (de) * 1996-10-28 2003-09-25 Novo Nordisk As Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
EP0934299A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129623A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
DK0937062T3 (da) * 1996-10-28 2003-04-07 Novo Nordisk As Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer
AU4772197A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
EP1282615B1 (en) 2000-03-01 2011-10-19 N.V. Organon Chroman derivatives as estrogenic compounds
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CA2816319C (en) 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PT2953938T (pt) 2014-02-07 2017-10-09 Novogen ltd Compostos de benzopirano funcionais e sua utilização
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
MX9705219A (es) 1997-10-31
IL116746A0 (en) 1996-05-14
CN1168096A (zh) 1997-12-17
NO973243D0 (no) 1997-07-11
AU693628B2 (en) 1998-07-02
HUP9702244A3 (en) 1999-12-28
EP0804190A1 (en) 1997-11-05
JPH10511962A (ja) 1998-11-17
CA2208861A1 (en) 1996-07-18
HUP9877967A2 (en) 1998-12-28
AU4329396A (en) 1996-07-31
WO1996021444A1 (en) 1996-07-18
NO973243L (no) 1997-07-11

Similar Documents

Publication Publication Date Title
CZ212297A3 (en) Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of gynecological diseases
RU2166940C2 (ru) Способ уменьшения потерь костной ткани, способ лечения остеопороза и применение соединения
US5726202A (en) Benign prostatic hypertrophy
US5747059A (en) Atrophy of skin/mucous membrane
US5883118A (en) Prostatic carcinoma
CZ217298A3 (cs) Použití 3,4-difenyl chromanů pro výrobu farm. prostředku
CZ217198A3 (cs) Použití L-enantiomeru centochromanu pro výrobu farmaceutického prostředku
CZ212397A3 (en) Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
CZ212497A3 (en) Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of idiopathic or physiological gynecomastia
JPH10512270A (ja) 肥満の治療又は予防のための医薬製剤の製造のための３，４−ジフェニル・クロマンの使用
CZ211897A3 (en) Use of 3,4-diphenylchromans for preparing pharmaceutical preparations used for dilation of vessels
US5780502A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
KR19980701383A (ko) 부인병 질환의 치료 또는 예방용 약학적 조성물의 제조를 위한 3,4-디페닐크로만의 사용(use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia)
MXPA97005219A (en) Use of 3,4-difenil-chromanos for the manufacture of a pharmaceutical composition for the treatment of profilaxis of disorders ginecologi
EP0954307A1 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
HUT76855A (en) Use of benzotiophene derivatives for production pharmaceutical compositions useful for bone healing and fracture repair
EP0771201B1 (en) Use of 2-phenyl-3-aroylbenzothiophenes for the preparation of a medicament for inhibiting primary endometrial hyperplasia
KR19980701384A (ko) 측발성 또는 생리적 여성형유방의 치료 또는 예방용 약학적 조성물의 제조를 위한 3,4-디페닐크로만의 사용
MXPA97005218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica